Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction.
Chloroquine induced a myasthenic syndrome in a patient taking the drug for presumable reticular erythematous mucinosis. Clinical features and results of single-fiber electromyography were typical for a failure of neuromuscular transmission, while peripheral nerves and muscles were intact on clinical, biochemical, electrophysiologic, and pathologic investigation. The time course of the clinical and electrophysiologic findings during provocation with chloroquine and the absence of autoantibodies indicate that the syndrome was due to a direct effect of the drug on the neuromuscular junction. While not taking chloroquine, the patient showed a decremental response on a modified double-step nerve stimulation test and a mean consecutive difference on single-fiber electromyography that was at the upper limit of normal, indicating a subclinical impairment of neuromuscular transmission. These findings can explain the apparent rarity of the syndrome described, as a direct effect of chloroquine on the neuromuscular junction may only have clinical relevance in patients with a reduced neuromuscular safety factor.
Robberecht
W
W
Department of Neurology, University Hospital Leuven, Belgium.
Bednarik
J
J
Bourgeois
P
P
van Hees
J
J
Carton
H
H
D000328:Adult; D002738:Chloroquine / Q000009:adverse effects* / Q000627:therapeutic use; D004558:Electric Stimulation; D004576:Electromyography; D004890:Erythema / Q000188:drug therapy; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000187:drug effects*; D013577:Syndrome; D014459:Ulnar Nerve / Q000503:physiopathology
D002738:Chloroquine